Abstract
High-grade urothelial carcinoma (HGUC) is diagnosed using major criteria which include high N/C ratio, irregular nuclear membranes, and coarse chromatin. TPS second edition recognizes these criteria to be stringent in order to normalize the cytomorphologic heterogeneity of HGUC on urine samples and has included notable variances which may be present in urine samples. These variances are most notably N/C ratios that have a wide range in tumor cells and hypochromasia in select cases, along with HGUC sub-types, all of which impact cytologic interpretation. Degeneration of tumor cells also affects diagnosis of HGUC. The recognition of the major criteria and the variances will help in diagnosis of HGUC on cytologic specimens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Siddiqui MT, Fadda G, Han JH, Owens CL, Tabatabai ZL, Tsuzuki T. High Grade Urothelial Carcinoma (HGUC). In: Rosenthal DL, Wojcik EM, Kurtycz DFI, editors. The Paris system for reporting urinary cytology. Springer; 2016. p. 61–74.
Koh HH, Lee MJ, Park NJ, Kim H-S, Oh YL. Impact of implementing the Paris system for reporting urinary cytology: a single-institutional experience with emphasis on diagnostic yield of high-grade urothelial carcinoma and low-grade urothelial neoplasm. Anticancer Res. 2020;40(6):3477–84.
Danakas A, Sweeney M, Cheris S, Agrawal T. Urinary tract cytology: a cytologic-histopathologic correlation with the Paris system, an institutional study. J Am Soc Cytopathol. 2021;10(1):56–63.
Anbardar MH, Monjazeb R. Reclassification of urinary cytology regarding the Paris system for reporting urinary cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma. Diagn Cytopathol. 2020;48(5):446–52.
Cowan ML, VandenBussche CJ. The Paris system for reporting urinary cytology: early review of the literature reveals successes and rare shortcomings. J Am Soc Cytopathol. 2018;7:185–94.
Kurtycz DFI, Sundling KE, Barkan GA. The Paris system for reporting urinary cytology: strengths and opportunities. Diagn Cytopathol. 2020;48:890–5.
Pastorello RG, Barkan GA, Saieg M. Experience on the use of the Paris system for reporting urinary cytopathology: review of the published literature. J Am Soc Cytopathol. 2021;10(1):79–87.
Meilleroux J, Daniel G, Aziza J, Md’Aure D, Quintyn-Ranty ML, Basset CMI, Evrad SM, Courtade-Saidi MM. One year of experience using the Paris system for reporting urinary cytology. Cancer Cytopathol. 2018;126:430–6.
Stanzione N, Ahmed T, Fung PC, Cai D, Lu DY, Sumida LC, Moatamed NA. The continual impact of the Paris system on urine cytology, a 3-year experience. Cytopathology. 2020;31:35–40.
De Paula R, Oliveira A, Nunes W, Bovolim G, Domingos T, Brot LD, Bezerra S, Cunha I, Morini M, Saieg M. Two-year study on the application of the Paris system for urinary cytology in a cancer center. Cytopathology. 2020;31:41–6.
Cowan ML, Rosenthal DL, VandenBussche CJ. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris system for reporting urinary cytology. Cancer Cytopathol. 2017;125:427–34.
Pierconti F, Martini M, Straccia P, Fiorentino V, Musarra T, Larocca LM, Lopez-Beltran A. Hypochromatic large urothelial cells in urine cytology are indicative of high-grade urothelial carcinoma. APMIS. 2018;126:705–9.
Renshaw AA, Gould EW. High-grade urothelial carcinoma with hypochromatic chromatin in urine cytology. J Am Soc Cytopathol. 2021;10:25–8.
Renshaw AA, Gould EW. High-grade urothelial carcinoma on urine cytology resembling umbrella cells. Acta Cytol. 2018;62:62–7.
Renshaw AA, Gould EW. High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin. Cancer Cytopathol. 2018;126:64–8.
Vaickus LJ, Tambouret RH. Young investigator challenge: the accuracy of the nuclear-to-cytoplasmic ratio estimation among trained morphologists. Cancer Cytopathol. 2015;123(9):524–30.
Layfield LJ, Esebua M, Frazier SR, Hammer RD, Bivin WW, Nguyen V, Ersoy I, Schmidt RL. Accuracy and reproducibility of nuclear/cytoplasmic ratio assessments in urinary cytology specimens. Diagn Cytopathol. 2017;45(2):107–12.
Zhang ML, Guo AX, VandenBussche CJ. Morphologists overestimate the nuclear-to-cytoplasmic ratio. Cancer Cytopathol. 2016;124(9):669–77.
McIntire PJ, Snow JT, Elsoukkary SS, Soong L, Sweeney J, Robinson BD, Siddiqui MT. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens. Cancer Cytopathol. 2019;127(2):120–4.
Allison DB, Olson MT, Lilo M, Zhang ML, Rosenthal DL, VandenBussche CJ. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens? Cancer Cytopathol. 2016;124(6):436–42.
Suh J, Go H, Sung C, et al. Modification of the Paris system for urinary tract washing specimens using diagnostic cytological features. Cytopathology. 2017;28(6):516–23.
Moch H. International Agency for Research on C. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon: International Agency for Research on Cancer; 2016.
Yoo Y, Choi E, Lee DH, Park S, Sung SH. Diagnostic value of urine cytology in detecting histologic variants of urothelial carcinoma in the urinary bladder: Cytopathologic correlation of 72 cases. Diagn Cytopathol. 2021;49(3):367–73.
Cardillo M, Reuter VE, Lin O. Cytologic features of the nested variant of urothelial carcinoma. Cancer Cytopathol. 2003;99(1):23–7.
Suo L, Vega I, Thrall M. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in the Paris system for reporting urine cytology ? J Am Soc Cytopathol. 2021;10:20–4.
Straccia P, Martini M, Sacco E, Bassi PF, Pierconti F. Cytological feature of micropapillary and plasmacytoid variants of urothelial carcinoma. Diagn Cytopathol. 2020;48:111–7.
Chan E, Balassanian R, Tabatabai ZL, Lou H, Vohra P. Improved diagnostic precision of urine cytology by implementation of the Paris system and the use of cell blocks. Cancer Cytopathol. 2018;126(9):809–16.
Straccia P, Bizzarro T, Fadda G, Pierconti F. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris system for reporting urinary cytology. Cancer Cytopathol. 2016;124(7):519–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Siddiqui, M.T. et al. (2022). High-Grade Urothelial Carcinoma (HGUC). In: Wojcik, E.M., Kurtycz, D.F., Rosenthal, D.L. (eds) The Paris System for Reporting Urinary Cytology. Springer, Cham. https://doi.org/10.1007/978-3-030-88686-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-88686-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-88685-1
Online ISBN: 978-3-030-88686-8
eBook Packages: MedicineMedicine (R0)